DEACETYLNORGESTIMATE (25 MG) ((E)- AND (Z)-17-DEACETYL NORGESTIMATE MIXTURE)

DEACETYLNORGESTIMATE (25 MG) ((E)- AND (Z)-17-DEACETYL NORGESTIMATE MIXTURE) Struktur
53016-31-2
CAS-Nr.
53016-31-2
Englisch Name:
DEACETYLNORGESTIMATE (25 MG) ((E)- AND (Z)-17-DEACETYL NORGESTIMATE MIXTURE)
Synonyma:
RWJ 10553;BRN 4202099;levonorgestreloxime;D-Norgestrel 3-oxime;(-)-NorelgestroMin-d6;Desacetylnorgestimate;17-Deacylnorgestimate;Levonorgestrel 3-oxime; 17-Deacetylnorgestimate;Norelgestromin (1468454)
CBNumber:
CB1500552
Summenformel:
C21H29NO2
Molgewicht:
327.46
MOL-Datei:
53016-31-2.mol

DEACETYLNORGESTIMATE (25 MG) ((E)- AND (Z)-17-DEACETYL NORGESTIMATE MIXTURE) Eigenschaften

Schmelzpunkt:
107-109°C
Siedepunkt:
491.9±45.0 °C(Predicted)
Dichte
1.23±0.1 g/cm3(Predicted)
storage temp. 
Sealed in dry,2-8°C
Löslichkeit
DMF: 11 mg/ml; DMSO: 10 mg/ml; Ethanol: 12 mg/ml; PBS (pH 7.2): 0.25 mg/ml
Aggregatzustand
A solid
pka
12.22±0.60(Predicted)
CAS Datenbank
53016-31-2
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
HS Code  2937230000
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Achtung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H351 Kann vermutlich Krebs verursachen. Karzinogenität Kategorie 2 Warnung P201, P202, P281, P308+P313, P405,P501
H360 Kann die Fruchtbarkeit beeinträchtigen oder das Kind im Mutterleib schädigen. Fertility (Fruchtbarkeit) Kategorie 1 Achtung GHS hazard pictogramssrc="/GHS08.jpg" width="20" height="20" />
Sicherheit
P201 Vor Gebrauch besondere Anweisungen einholen.
P308+P313 BEI Exposition oder falls betroffen: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.

DEACETYLNORGESTIMATE (25 MG) ((E)- AND (Z)-17-DEACETYL NORGESTIMATE MIXTURE) Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Ortho Evra@ is the first birth control transdermal patch and contains a combination of norelgestromin and ethinylestradiol. The patch can be applied to the buttocks, lower abdomen, upper torso or arms; changed weekly for 3 weeks, followed by a patch-free week. Norelgestromin is the active metabolite produced following oral administration of norgestimate, the progestin component of the contraceptive, Ortho-Cyclen?. The half-life value of norelgestromin was approximately 28 h. Following application, norelgestromin rapidly appeared in the serum, reached a plateau by approximately 48h and was maintained at an approximate steady state throughout the wear period. Hepatic metabolites of norelgestromin included norgestrel and various hydroxylated and conjugated metabolites that were eliminated by renal and fecal pathways. Ortho Evra produced ovarian suppression and cycle control. It was significantly more effective in suppressing follicular development than the leading oral contraceptive Triphasil? (ethinyl estradiol/levomorgestrel); was as effective in preventing pregnancies and had similar tolerability profile. The patch offers 99% efficacy when used appropriately, as shown by three clinical trials. However, a statistically significantly greater proportion of pregnancies occurred among women weighing 90 kg or more. Ortho Evra? was well tolerated, with 2.6% of women discontinuing treatment due to mild to moderate reactions at the site of application. Thus, the patch combined the efficacy of oral contraceptives with the convenience of just once-weekly dosing.

Chemische Eigenschaften

White Solid

DEACETYLNORGESTIMATE (25 MG) ((E)- AND (Z)-17-DEACETYL NORGESTIMATE MIXTURE) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


DEACETYLNORGESTIMATE (25 MG) ((E)- AND (Z)-17-DEACETYL NORGESTIMATE MIXTURE) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 57)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
Nanjing Doge Biomedical Technology Co., Ltd
+86-25-58227606 +86-15305155328
sales@dogechemical.com China 4128 58
Shanghai Acmec Biochemical Technology Co., Ltd.
+undefined18621343501
product@acmec-e.com China 33350 58
Aladdin Scientific
+1-833-552-7181
sales@aladdinsci.com United States 52927 58
Amadis Chemical Company Limited
571-89925085
sales@amadischem.com China 131981 58
J & K SCIENTIFIC LTD. 010-82848833 400-666-7788
jkinfo@jkchemical.com China 96815 76
LGM Pharma 1-(800)-881-8210
inquiries@lgmpharma.com United States 2127 70
Chemsky(shanghai)International Co.,Ltd. 021-50135380
shchemsky@sina.com China 32344 50
Sinopharm Chemical Reagent Co,Ltd. 86-21-63210123
sj_scrc@sinopharm.com China 9823 79
BOC Sciences 1-631-485-4226; 16314854226
info@bocsci.com United States 14059 65

53016-31-2()Verwandte Suche:


  • (17α)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one OxiMe
  • (17α)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one-d6 OxiMe
  • (-)-NorelgestroMin-d6
  • (17alpha)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one oxime
  • (E)- and (Z)-17-Deacetylnorgestimate mixture
  • Norgestimate metabolite Norelgestromin
  • 17-Desacetyl Norgestimate ((E)- AND (Z)-17-DEACETYL NORGESTIMATE MIXTURE)
  • Deacetylnorgestimate (Mixture of (E)- And (Z)-17-Deacetyl Norgestimate)
  • (17R)-13-Ethyl-17-hydroxy-18,19-dinor-pregna-4-ene-20-yne-3-oneoxime
  • [17R,(+)]-17-Hydroxy-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one oxime
  • [17R,(+)]-17-Hydroxy-13-ethyl-18,19-dinorpregna-4-ene-20-yne-3-oneoxime
  • Desacetylnorgestimate
  • DEACETYLNORGESTIMATE (25 MG) ((E)- AND (Z)-17-DEACETYL NORGESTIMATE MIXTURE)
  • ,10-alpha,13-alpha,14-beta)-
  • 18,19-dinorpregn-4-en-20-yn-3-one,13-ethyl-17-hydroxy-,oxime,(8-alpha,9-beta
  • levonorgestreloxime
  • 17-Deacetylnorgestimate
  • (17a)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one Oxime
  • 18-Methylnorethindrone oxime
  • BRN 4202099
  • D-Norgestrel 3-oxime
  • Levonorgestrel 3-oxime
  • RWJ 10553
  • 13-ETHYL-17_-HYDROXY-18,19-DINORPREGN-4-EN-20-YN-3-ONE OXIME
  • 17-Desacetyl Norgestimate Solution, 100ppm
  • 17-Desacetyl Norgestimate (Mixture of Isomers)
  • 17-Deacylnorgestimate
  • 17-Desacetyl Norgestimate-d7 (Mixture ofIsomers) (Norelgestromin-d7)
  • 17-Desacetyl Norgestimate (Mixture of Isomers) (Norelgestromin)
  • 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, oxime, (17α)-
  • (E/Z)-17-Deacetylnorgestimate
  • 17-Desacetyl NorgestimateQ: What is 17-Desacetyl Norgestimate Q: What is the CAS Number of 17-Desacetyl Norgestimate Q: What is the storage condition of 17-Desacetyl Norgestimate Q: What are the applications of 17-Desacetyl Norgestimate
  • Norelgestromin (1468454)
  • Deacetylnorgestimate ((E)- and (Z)-17-deacetyl norgestimate mixture) (1471958)
  • Deacetylnorgestimate (Mixture of (E)- And (Z))
  • Drug Metabolite,inhibit,Inhibitor,Norgestimate metabolite Norelgestromin
  • Deacetylnorgestimate ((E)- and (Z)-17-deacetyl norgestimate mixture)
  • (8R,9S,10R,13S,14S,17R,E)-13-ethyl-17-ethynyl-17-hydroxy-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one oxime
  • Deacetylnorgestimate (25 mg) ((E)- and (Z)-17-deacetyl norgestimate mixture) (PLANNED TO BE DISCONTINUED)
  • Norgestimate metabolite Norelgestromin (mixture of isomers)
  • 53016-31-2
  • Various Metabolites and Impurities
  • Intermediates & Fine Chemicals
  • Metabolites & Impurities
  • Pharmaceuticals
  • Steroids
Copyright 2019 © ChemicalBook. All rights reserved